@article{Tjoa_Joon_Angeline_A. Lieputra_Edbert_Hartati Moehario_2022, title={Carbapenemase Detection Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates Using a Modified Blue-Carba Test}, volume={12}, url={https://igjps.com/index.php/IGJPS/article/view/76}, DOI={10.35652/IGJPS.2022.12027}, abstractNote={<p><strong>Objective</strong>: <em>Acinetobacter baumannii</em> is a Gram-negative opportunistic bacteria with carbapenemase-associated antibiotic resistance accounting for a majority of nosocomial infections globally. We sought to detect carbapenemase producers among carbapenem-resistant <em>A. baumannii</em> (CRAB) clinical isolates using Blue-Carba Test (BCT). <strong>Methods</strong>: This study was an observational descriptive study. At first, <em>A. baumannii</em> clinical isolates (142) were collected from January 2014 to September 2017 and stored at the Microbiology Laboratory of the Faculty of Medicine, Atma Jaya Hospital. Next step involved the identification of the carbapenem-resistant isolates using WHONET 5.3 software (<a href="https://whonet.org/software.html">https://whonet.org/software.html</a>). Here, Imipenem and Meropenem served as markers. Finally, the identified carbapenem-resistant isolates were subjected to Blue-Carba Test. <strong>Results</strong>: Among 142 <em>A. baumannii</em> isolates, 51.4% (73/142) were identified as CRAB. Of these, 36 isolates were revived and all were found to be carbapenemase positive. <strong>Conclusion</strong>: Conclusively, a cent percent (36/36) prevalence of carbapenemase producers was observed in the CRAB group, which is an important clinical finding for antibiotic selection against <em>A. baumannii</em> infection. © 2022 iGlobal Research and Publishing Foundation. All rights reserved.</p>}, journal={Indo Global Journal of Pharmaceutical Sciences}, author={Tjoa, Enty and Joon, Shikha and Angeline, Dianita and A. Lieputra, Andrew and Edbert, Daniel and Hartati Moehario, Lucky}, year={2022}, month={Aug.}, pages={216–219} }